Related Experiment Videos
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers
Abstract:
A series of plasmid vectors containing the multiple cloning site (MCS7) of M13mp7 has been constructed. In one of these vectors a kanamycin-resistance marker has been inserted into the center of the symmetrical MCS7 to yield a restriction-site-mobilizing element (RSM). The drug-resistance marker can be cleaved out of this vector with any of the restriction enzymes that recognize a site of the flanking sequences of the RSM to generate an RSM with either various sticky ends or blunt ends. These fragments can be used for insertion mutagenesis of any target molecule with compatible restriction sites. Insertion mutants are selected by their resistance to kanamycin. When the drug-resistance marker is removed with PstI, a small in-frame insertion can be generated. In addition, two new MCSs having single restriction sites have been formed by altering the symmetrical structure of MCS7. The resulting plasmids pUC8 and pUC9 allow one to clone doubly digested restriction fragments separately with both orientations in respect to the lac promoter. The terminal sequences of any DNA cloned in these plasmids can be characterized using the universal M13 primers.
Insights
Researchers developed novel plasmid vectors for insertion mutagenesis. These vectors facilitate targeted DNA modifications and gene insertions using kanamycin resistance for selection, enabling precise genetic engineering.
Area of Science:
- Molecular Biology
- Genetic Engineering
- Recombinant DNA Technology
Background:
- Plasmid vectors are essential tools in molecular biology for gene cloning and manipulation.
- Existing vectors may have limitations in flexibility for insertion mutagenesis and orientation control.
- The M13mp7 multiple cloning site (MCS7) offers a basis for developing improved cloning vectors.
Purpose of the Study:
- To construct novel plasmid vectors with enhanced capabilities for insertion mutagenesis.
- To create a restriction-site-mobilizing element (RSM) for targeted DNA fragment insertion.
- To develop new MCSs for directional cloning and sequence characterization.
Main Methods:
- Construction of plasmid vectors incorporating the M13mp7 MCS7.
- Insertion of a kanamycin-resistance marker into MCS7 to create a restriction-site-mobilizing element (RSM).
- Modification of MCS7 to generate new MCSs (pUC8 and pUC9) with single restriction sites.
- Utilizing M13 universal primers for DNA sequence characterization.
Main Results:
- Successfully generated RSMs that can be cleaved to produce fragments with various sticky or blunt ends for insertion mutagenesis.
- Demonstrated selection of insertion mutants via kanamycin resistance.
- Developed pUC8 and pUC9 plasmids enabling directional cloning of restriction fragments in both orientations relative to the lac promoter.
- Confirmed the utility of M13 primers for characterizing cloned DNA termini.
Conclusions:
- The developed plasmid vectors provide versatile tools for insertion mutagenesis and genetic manipulation.
- The RSM strategy allows for efficient and selectable introduction of DNA fragments into target molecules.
- New MCSs in pUC8 and pUC9 enhance cloning flexibility and facilitate sequence analysis.